Innovation Lab Introduces Boston Scientific, Dell, and Deloitte as Partners in Health Care Innovation at Open House

Newport Beach, Calif. – October 5, 2015 – The Innovation Institute hosted an open house for its Innovation Lab in Newport Beach, Calif. on October 1, 2015. Key partners, including Boston Scientific, Dell, and Deloitte were welcomed and honored as collaborators in health care innovation.

Harry Greenspun, M.D., director, Deloitte Center for Health Solutions, Deloitte Services LP, served as keynote speaker and spoke about a reengineering methodology that leads to better care to more people, at a lower cost. Greenspun was named one of the “50 Most Influential Physician Executives in Healthcare” by Modern Healthcare and co-authored the book “Reengineering Health Care.”
 
Also present were executives from each of The Innovation Institute’s “member owner” healthcare systems, including St. Joseph Health based in Irvine, California; Bon Secours Health System, based in Marriottsville, Maryland; Children’s Hospital of Orange County; and Franciscan Missionaries of our Lady Health System in Baton Rouge, Louisisana.
 
“This was a great gathering of like-minded people united for the purpose of transforming health care,” said Joe Randolph, president & CEO of The Innovation Institute. “We are pleased to be able to share the Innovation Lab that Petra Integrated Construction Services, LLC has designed to inspire innovation among our partners and member owners,” added Randolph.
 
“We look forward to collaborating with Boston Scientific, Dell, and Deloitte to harness technology to reduce costs and improve patient care,” said Larry Stofko, executive vice president of the Innovation Lab. The Innovation Lab continues to actively pursue relationships with additional industry partners in complementary market sectors and segments.
 
Lab partners have access to the thousands of health professionals affiliated with the Innovation Lab for focus group participation and ideation challenges, collaboration and joint development of medical products; as well as the Innovation Lab space to showcase new products and conduct meetings and conferences. 

About the Innovation Lab
The Innovation Lab is a subsidiary of The Innovation Institute, an independent, for-profit LLC structured to cultivate innovative solutions to transform healthcare delivery. The Innovation Institute is owned by non-profit health systems. This collaborative taps into physicians, employees, and industry business partners to incubate and commercialize new products and ideas through the Innovation Lab. Comprised of three distinct elements – an innovation lab, an investment fund, and a shared services group (Enterprise Development Group), The Institute strives to “do more, with less, for more people.” For more information, visit ww.ii4change.com.
 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.